Rapid Uptake of AI Medical Devices Outpaces Evidence of Their Effects on Patient Outcomes
-
By
-
Simon Spichak
-
November 11, 2026
Objective:
The article examines the rapid adoption of FDA-authorized AI medical devices and the limited evidence evaluating their effects on patient outcomes.
Approach:
- Regulatory pathways: The article describes FDA 510(k) clearance, which can rely on comparison with an existing device, and the more demanding de novo pathway for devices without an equivalent.
- Evidence and adoption: It cites a PLoS One study of FDA-authorized AI devices and interviews researchers about adoption, evaluation, and patient involvement.
Key Findings:
- By October 2026, the FDA had authorized 1,614 AI-enabled medical devices. A cited study found that only 3 of the 1,357 devices authorized at the time of its publication evaluated patient outcomes.
- Most devices have used the 510(k) clearance pathway; the article reports that only one of more than 100 devices cleared or approved in 2020 used the de novo pathway.
- Some routinely used AI tools, including ambient scribes and chatbots, may not require FDA approval.
- Researchers interviewed for the article describe pressure to deploy AI tools before evidence establishes their effectiveness, safety, or effect on patient outcomes.
- The article reports that clinicians and patients, including people from marginalized communities, may prioritize different outcomes.
Interpretation:
The article describes a gap between the pace of AI deployment and evidence about effects on patient outcomes. It reports calls for ongoing evaluation and dialogue with people who use or are affected by health care systems.
Limitations:
- The cited PLoS One study’s finding that 3 of 1,357 devices evaluated patient outcomes applies to devices authorized when the study was published.
- The article notes that some AI tools used in health care, including certain ambient scribes and chatbots, may fall outside FDA oversight.
Conclusion:
Whether patients are experiencing improved outcomes from AI adoption remains uncertain, according to the article.
Sources:
Based on findings from:
Despite Rapid Adoption, We Don't Know If Most AI Devices Improve Patient Outcomes
Simon Spichak. Journal Of Medical Internet Research, 2026.
https://www.jmir.org/2026/1/e115806
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
